The expression of the immune checkpoint regulator VISTA correlates with improved overall survival in pT1/2 tumor stages in esophageal adenocarcinoma

Immune checkpoint modulation in cancer has been demonstrated as a high-value therapeutic strategy in many tumor entities. VISTA is an immune checkpoint receptor regulating T-cell function. To the best of our knowledge, nothing is known about the expression and prognostic impact of VISTA on tumor inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Loeser, Heike, Kraemer, Max, Gebauer, Florian, Bruns, Christiane, Schröder, Wolfgang, Zander, Thomas, Persa, Oana-Diana, Alakus, Hakan, Hoelscher, Arnulf, Buettner, Reinhard, Lohneis, Philipp, Quaas, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492979/
https://www.ncbi.nlm.nih.gov/pubmed/31069143
http://dx.doi.org/10.1080/2162402X.2019.1581546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492979/
https://www.ncbi.nlm.nih.gov/pubmed/31069143
http://dx.doi.org/10.1080/2162402X.2019.1581546

Ejemplares similares